article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. However, they are vital to the drug development and approval process and critical in enabling access to innovative medicines.

article thumbnail

How AI is Shaping Drug Discovery at AION Labs

Healthcare IT Today

In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drug development processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Revolutionizing Medical AI Development: Flywheel Announces $54 Million in Series D Funding led by Novalis LifeSciences and NVentures

Healthcare IT Today

We are particularly excited about the ability of these tools to drive more efficient and faster drug development processes in the biopharma industry.” “The Flywheel helps organizations turn complex imaging data into analysis-ready datasets for accelerated research and AI development.

article thumbnail

How Happy Cells Manufacture New Medications

Healthcare IT Today

The development and manufacturing process for these important new drugs is very different from traditional medicines. This article focuses on the technology that ensures quality in the process, and is based on a conversation with Graziella Piras, PhD, Life Science Business Development Director at 908 Devices.

article thumbnail

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Digital Health Global

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

Given the improvements in costs, trial sponsors can now take advantage of these exchanges at scale and leverage the data for both pre-screening and health economic analysis. As DCTs and virtual site acceptance accelerates, a knock-on effect will be that more of these trials will include HEOR analysis.

article thumbnail

Pharma – 2023 Health IT Predictions

Healthcare IT Today

Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. Patient insight management will be a key strategic pillar: Life science organizations are more confident in the business value of insights management and are increasingly willing to commit the necessary technological resources to support this need.